Financial Perspectives, Inc Exact Sciences Corp Transaction History

Financial Perspectives, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 09, 2024	SELL	$72.5 - $100.68 $49,807 - $69,167	-687 Closed	0 $0
Q2 2021 Jan 09, 2024	SELL	$93.66 - $139.27 $8.27 Million - $12.3 Million	-88,265 Reduced 99.23%	687 $85.4 Million
Q1 2021 Jan 09, 2024	BUY	$116.57 - $155.01 $10.3 Million - $13.8 Million	88,741 Added 42057.35%	88,952 $675,000
Q4 2020 Jan 09, 2024	BUY	$99.61 - $142.12 $21,017 - $29,987	211 New	211 $28 Million

671

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.16B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Financial Perspectives, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Perspectives, Inc with notifications on news.